0000899243-17-024530.txt : 20171019 0000899243-17-024530.hdr.sgml : 20171019 20171019202940 ACCESSION NUMBER: 0000899243-17-024530 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171012 FILED AS OF DATE: 20171019 DATE AS OF CHANGE: 20171019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALDRICH RICHARD CENTRAL INDEX KEY: 0001185039 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36830 FILM NUMBER: 171145786 MAIL ADDRESS: STREET 1: 1365 MAIN STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KalVista Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348911 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200915291 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200, STE. 2203 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: (857) 999-0075 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BUILDING 200, STE. 2203 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Therapeutics, Inc. DATE OF NAME CHANGE: 20140916 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery, Inc DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Carbylan Biosurgery Inc DATE OF NAME CHANGE: 20060105 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-10-12 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001185039 ALDRICH RICHARD C/O LONGWOOD CAPITAL PRUDENTIAL TOWER, 800 BOYLSTON STREET, S BOSTON MA 02199 1 0 0 0 Common Stock 2017-10-12 4 P 0 565065 8.6131 A 934484 I See Footnote The reportable securities are owned directly by Longwood Fund II, LP, a Delaware limited partnership ("Longwood II"). Longwood Fund II GP, LLC, a Delaware limited liability company ("Longwood II GP"), is the general partner of Longwood II and exercises voting and investment power with respect to the securities owned directly by Longwood II. Longwood II's investment adviser is Longwood Fund Management, LLC ("Longwood Management"). Each of the Reporting Person, who is a member of the Issuer's board of directors, and Christoph Westphal, M.D., Ph.D. ("Westphal") are the Managers (and are members) of Longwood II GP and may be deemed to share voting and investment power with respect to the securities owned by Longwood II. (Continue from footnote 1) Each of the Reporting Person, Westphal, Longwood II GP and Longwood Management disclaims beneficial ownership of the shares held by Longwood II and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their respective pecuniary interests therein. /s/ Richard Aldrich 2017-10-19